We are live on
!
Find out more
EWM
Essex Woodlands Management Portfolio holdings
AUM
$254M
1-Year Est. Return
4.59%
This Fund
S&P 500
This Quarter
Est. Return
-8.99%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$414M
AUM Growth
-$31.1M
(-7%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
3.5%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
2
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TELA Bio
TELA
|
+$17.1M |
| 2 |
MiMedx Group
MDXG
|
+$191K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axogen
AXGN
|
+$2.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
TSM
IGM
WWM
MWM
LRIC
2
ACM
KAM
Essex Woodlands Management's Q1 2022 Portfolio in Review
As of Q1 2022, Essex Woodlands Management held 10 positions worth $414M, down 7% from $445M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Essex Woodlands Management deployed $14.5M of net new capital in Q1 2022, adding to 2 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the most notable exit was Axogen, an estimated $2.78M sold.
- Essex Woodlands Management added most to TELA Bio in Q1 2022, an estimated $17.1M increase.
- Essex Woodlands Management fully exited Axogen in Q1 2022, selling an estimated $2.78M.
- Essex Woodlands Management's ten largest holdings make up 100% of its $414M portfolio in Q1 2022.
- Essex Woodlands Management opened 0 new positions and closed 1 in Q1 2022.
- Essex Woodlands Management's portfolio value fell 7% quarter-over-quarter to $414M.
Based on Essex Woodlands Management's 13F filing for Q1 2022, filed 16 May 2022.